SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS

Clinical trials for SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS trials appear

Sign up with your email to follow new studies for SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Experimental pill targets specific cancer mutations in patients out of options

Disease control Completed

This study tested an oral medication called ENV-101 in adults with advanced solid tumors that have a specific genetic change (PTCH1 mutation) and have stopped responding to standard treatments. The goal was to see if the drug could shrink tumors and was safe to take. Researchers …

Matched conditions: SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS

Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control

Last updated Apr 02, 2026 09:12 UTC

SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS

Get alerted when new SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS trials appear

Experimental pill targets specific cancer mutations in patients out of options